Free Trial
NASDAQ:CPIX

Cumberland Pharmaceuticals (CPIX) Stock Price, News & Analysis

Cumberland Pharmaceuticals logo
$3.80 -0.09 (-2.19%)
As of 03:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Cumberland Pharmaceuticals Stock (NASDAQ:CPIX)

Key Stats

Today's Range
$3.61
$3.93
50-Day Range
$2.55
$5.89
52-Week Range
$1.04
$7.25
Volume
55,174 shs
Average Volume
870,030 shs
Market Capitalization
$56.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cumberland Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
18th Percentile Overall Score

CPIX MarketRank™: 

Cumberland Pharmaceuticals scored higher than 18% of companies evaluated by MarketBeat, and ranked 859th out of 937 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Cumberland Pharmaceuticals.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cumberland Pharmaceuticals is -15.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cumberland Pharmaceuticals is -15.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cumberland Pharmaceuticals has a P/B Ratio of 2.34. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Cumberland Pharmaceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    0.10% of the float of Cumberland Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Cumberland Pharmaceuticals has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cumberland Pharmaceuticals has recently decreased by 87.52%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Cumberland Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Cumberland Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.10% of the float of Cumberland Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Cumberland Pharmaceuticals has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cumberland Pharmaceuticals has recently decreased by 87.52%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Cumberland Pharmaceuticals has a news sentiment score of -0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.96 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for Cumberland Pharmaceuticals this week, compared to 10 articles on an average week.
  • MarketBeat Follows

    1 people have added Cumberland Pharmaceuticals to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cumberland Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    44.85% of the stock of Cumberland Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 15.51% of the stock of Cumberland Pharmaceuticals is held by institutions.

  • Read more about Cumberland Pharmaceuticals' insider trading history.
Receive CPIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CPIX Stock News Headlines

Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
See More Headlines

CPIX Stock Analysis - Frequently Asked Questions

Cumberland Pharmaceuticals' stock was trading at $2.37 at the start of the year. Since then, CPIX shares have increased by 58.9% and is now trading at $3.7650.

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced its quarterly earnings results on Tuesday, May, 6th. The specialty pharmaceutical company reported $0.15 EPS for the quarter. Cumberland Pharmaceuticals had a positive trailing twelve-month return on equity of 6.92% and a negative net margin of 7.98%.
Read the conference call transcript
.

Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cumberland Pharmaceuticals investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Exxon Mobil (XOM), Netflix (NFLX) and Intel (INTC).

Company Calendar

Last Earnings
5/06/2025
Today
7/17/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:CPIX
CIK
1087294
Employees
80
Year Founded
1999

Profitability

EPS (Trailing Twelve Months)
($0.25)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.48 million
Net Margins
-7.98%
Pretax Margin
-8.08%
Return on Equity
6.92%
Return on Assets
2.33%

Debt

Debt-to-Equity Ratio
0.18
Current Ratio
1.25
Quick Ratio
1.09

Sales & Book Value

Annual Sales
$41.08 million
Price / Sales
1.37
Cash Flow
$0.28 per share
Price / Cash Flow
13.61
Book Value
$1.61 per share
Price / Book
2.34

Miscellaneous

Outstanding Shares
14,961,000
Free Float
8,251,000
Market Cap
$56.33 million
Optionable
Optionable
Beta
-0.39

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:CPIX) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners